UCB’s Post

View organization page for UCB, graphic

267,256 followers

🌐 A strong half-year start for UCB, setting the tone for our decade of growth! Our journey is just beginning, powered by a deep commitment to delivering differentiated solutions for people living with severe diseases. This commitment is bringing to life an impressive portfolio that is driving growth and success. Our robust financial performance and key regulatory milestones signal a promising future https://lnkd.in/euB5uiXZ Stay tuned for more updates! 

Half-year results 2024: strong start into UCB’s decade of growth | UCB

Half-year results 2024: strong start into UCB’s decade of growth | UCB

ucb.com

Dr. SUMANTOKE BAGCHI

HEAD MEDICAL AFFAIRS, RA & PV EXELTIS INDIA , A PART OF INSUD GROUP

2mo

Fantastic

Like
Reply

Great news! Congratulations 🎊

Like
Reply

前進しましょう。がんばってください。陰ながら応援させていただきます。

Like
Reply
Karen Rizks

Life Sciences-Biopharma Developer

2mo

Great news! Congrats UCB & Cheers for a continuous journey of growth & success!

Like
Reply

Wow! Congratulations on these results!

Like
Reply
Cedric Rebeiro

E2E Supply Chain Strategy & Operations | Pharmaceutical | Active Pharmaceutical Ingredients | Consumer Health & FMCG | SCMC CoE @ IIMB | Management Consulting | India | GCC, Levant, Iran, Iraq | AfMET

2mo

Keep growing!

Like
Reply
Dnyaneshwar B.

Biologics| Upstream Cell Culture Process Development| Scale-up | Technology Transfer | Process Characterisation|Process Validation|QbD| DoE|MSAT

2mo

Exciting times!

Like
Reply
Vipin Garg

Overall ~19 Years’ of experience in F&A, Assistant vice president at Genpact

2mo

Exciting times! Congratulations

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics